Which of the following is a therapeutic drug class for ibuprofen?

A. Ibuprofen does not possess any pharmacological affinity for mu-opioid receptors. It does not mitigate withdrawal symptoms or block the effects of exogenous opioids like methadone or buprenorphine. It is not indicated for the management of opioid use disorder or dependence. B. While this agent can affect renal hemodynamics by inhibiting vasodilatory prostaglandins, it is not classified as a renal therapeutic drug. It is not used to treat primary kidney diseases or improve renal clearance. Prolonged use may actually cause nephrotoxicity. C. This medication does not modulate bone mineral density or inhibit osteoclast activity. It lacks the mechanism of bisphosphonates or selective estrogen receptor modulators used to treat bone loss. It is not a therapeutic class for the management of osteoporosis. D. Ibuprofen is a nonsteroidal anti-inflammatory drug that non-selectively inhibits cyclooxygenase 1 and 2 enzymes. This action reduces the synthesis of proinflammatory prostaglandins from arachidonic acid. It is clinically indicated for the management of inflammatory pain, fever, and dysmenorrhea.